Use of selective adenosine a1 receptor agonists, antagonists and allosteric enhancers to manipulate angiogenesis

摘要

Disclosed is the use of selective adenosine A1 allosteric enhancers to induce angiogenesis at a desired location for treating conditions in which increased angiogenesis is desired, such as stroke, heart disease and peripheral vascular disease.